Insight Molecular Diagnostics: Q3 Earnings Snapshot

Resumen detallado
NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $3.6 million in its third quarter. On a per-share basis, the…
NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $3.6 million in its third quarter.
On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 10 cents. Losses, adjusted for non-recurring gains, came to 19 cents per share.
The cancer diagnostic test developer posted revenue of $559,000 in the period.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDX at https://www.zacks.com/ap/IMDX
Inicio del artículo, extracto de Yahoo Finance. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)



